IOZK Aktuelles Archive - Seite 11 von 15 - IOZK

Dendritic cell-based immunotherapy in ovarian cancer

2013-11-06/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer /von 2013-11-06 / Oncoimmunology 2013 Dec;2(12):e27059

Immunotherapy for high-grade glioma: how to go beyond Phase I/II clinical trials

2013-10-01/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-10-01 / Immunotherapy 2013 Oct;5(10):1043-6

Immunological response after WT1 mRNA-loaded dendritic cell immunotherapy in ovarian carcinoma and carcinosarcoma

2013-09-01/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Ovarian Cancer /von 2013-09-01 / Anticancer Res. 2013 Sep;33(9):3855-9

Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

2013-08-14/in Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2013-08-14 / Cancers (Basel) 2013 Aug;5(3):1020-48

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host

2013-07-02/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2013-07-02 / Biology (Basel) 2013 Jul;2(3):936-75

Science kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“

2013-04-12/in Externe Meldungen /von IOZK

Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future

2013-02-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2013-02-01 / BioDrugs 2013 Feb;27(1):35-53

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

2012-04-22/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44

TV-Beitrag-National Institutes of Health: Will Dendritic Cell Subsets help us address the challenges of Cancer, Autoimmunity and Viral Diseases?

2012-01-24/in Externe Meldungen /von IOZK

Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation

2012-01-01/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2012-01-01 / Methods Mol. Biol. 2012;797:177-204